Hypomethylation of the Toll-like receptor-2 gene increases the risk of essential hypertension

Mao,Shuqi; Gu,Tianlun; Zhong,Fade; Fan,Rui; Zhu,Fubao; Ren,Peipei; Yin,Fengying; Zhang,Lina

doi:10.3892/mmr.2017.6653

Hypomethylation of the Toll-like receptor-2 gene increases the risk of essential hypertension

Authors:
- Shuqi Mao
- Tianlun Gu
- Fade Zhong
- Rui Fan
- Fubao Zhu
- Peipei Ren
- Fengying Yin
- Lina Zhang
View Affiliations

Affiliations: Department of Preventive Medicine, Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, P.R. China, The Central Blood Station of Ningbo, Ningbo, Zhejiang 315211, P.R. China, Health and Family Planning Commission of Zhenhai, Ningbo, Zhejiang 315211, P.R. China, Clinical Laboratory, Baizhang Street Community Health Service Center of JiangDong, Ningbo, Zhejiang 315211, P.R. China, Clinical Laboratory, The First Hospital of Ningbo, Ningbo, Zhejiang 315010, P.R. China
Published online on: May 30, 2017 https://doi.org/10.3892/mmr.2017.6653
Pages: 964-970

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Studies on the etiology of essential hypertension (EH) have demonstrated that chronic inflammation contributes to the onset and development of elevated blood pressure. Toll‑like receptors (TLRs), important immune receptors, serve a role in chronic inflammation and are associated with EH. In the present study, 96 patients with EH, and 96 age‑ and sex‑matched healthy controls were recruited, and eight cytosine‑phosphate‑guanine (CpG) dinucleotides (CpG1‑8) were analyzed using bisulfite pyrosequencing technology. It was observed that the methylation levels of all of the eight CpG dinucleotides were decreased in the EH group compared with the control group; however, only CpG1 (2.83±1.34 vs. 3.44±1.75; P=0.009), CpG6 (3.58±3.64 vs. 8.30±4.13; P<0.001) and CpG8 (8.91±5.32 vs. 11.33±3.87; P<0.001) were significantly different, as demonstrated by paired t‑test analysis. In addition, logistic regression analysis demonstrated that CpG6 hypomethylation was a risk factor of EH (odds ratio=1.10; adjusted P=0.009), and CpG6 methylation level was observed to be negatively correlated with systolic blood pressure (r=‑0.304; P<0.001) and diastolic blood pressure (r=‑0.329; P<0.001). Additionally, receiver operating characteristic curve analysis demonstrated that a methylation level of 7.5% for CpG6 (area under the curve, 0.834; P<0.001) was an appropriate threshold value to predict the risk of EH. With generalized multifactor dimensionality reduction, a potential gene‑gene interaction between CpG6 and CpG8 (P=0.001), and gene‑environment interactions between smoking, alcohol consumption, CpG6, CpG7 and CpG8 (P=0.011), were observed. In conclusion, the results of the present study demonstrated that hypomethylation of the TLR2 promoter, particularly CpG6, was associated with the risk of EH in this population. Additionally, a gene‑gene interaction between CpG6 and CpG8, and interactions between environmental factors, including smoking and alcohol consumption, and CpG6, CpG7 and CpG8, may be associated with the risk of EH.

View Figures

View References

1	Oliveras A and de la Sierra A: Resistant hypertension: Patient characteristics, risk factors, co-morbidities and outcomes. J Human hypertens. 28:213–217. 2014. View Article : Google Scholar
2	Li D, Lv J, Liu F, Liu P, Yang X, Feng Y, Chen G and Hao M: Hypertension burden and control in mainland China: Analysis of nationwide data 2003–2012. Int J Cardiol. 184:637–644. 2015. View Article : Google Scholar : PubMed/NCBI
3	Virdis A, Dell'Agnello U and Taddei S: Impact of inflammation on vascular disease in hypertension. Maturitas. 78:179–183. 2014. View Article : Google Scholar : PubMed/NCBI
4	Dinh QN, Drummond GR, Sobey CG and Chrissobolis S: Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int. 2014:4069602014. View Article : Google Scholar : PubMed/NCBI
5	Bautista LE, Vera LM, Arenas IA and Gamarra G: Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 19:149–154. 2005. View Article : Google Scholar : PubMed/NCBI
6	Aliprantis AO, Yang RB, Weiss DS, Godowski P and Zychlinsky A: The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 19:3325–3336. 2000. View Article : Google Scholar : PubMed/NCBI
7	Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S and Janeway CA Jr: MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell. 2:253–258. 1998. View Article : Google Scholar : PubMed/NCBI
8	O'Neill LA and Greene C: Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol. 63:650–657. 1998.PubMed/NCBI
9	Alexeeff SE, Baccarelli AA, Halonen J, Coull BA, Wright RO, Tarantini L, Bollati V, Sparrow D, Vokonas P and Schwartz J: Association between blood pressure and DNA methylation of retrotransposons and pro-inflammatory genes. Int J Epidemiol. 42:270–280. 2013. View Article : Google Scholar : PubMed/NCBI
10	Marketou ME, Kontaraki JE, Zacharis EA, Kochiadakis GE, Giaouzaki A, Chlouverakis G and Vardas PE: TLR2 and TLR4 gene expression in peripheral monocytes in nondiabetic hypertensive patients: The effect of intensive blood pressure-lowering. J Clin Hypertens (Greenwich). 14:330–335. 2012. View Article : Google Scholar : PubMed/NCBI
11	Dange RB, Agarwal D, Teruyama R and Francis J: Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension. J Neuroinflammation. 12:312015. View Article : Google Scholar : PubMed/NCBI
12	Favre J, Musette P, Douin-Echinard V, Laude K, Henry JP, Arnal JF, Thuillez C and Richard V: Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol. 27:1064–1071. 2007. View Article : Google Scholar : PubMed/NCBI
13	Mullick AE, Soldau K, Kiosses WB, Bell TA III, Tobias PS and Curtiss LK: Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med. 205:373–383. 2008. View Article : Google Scholar : PubMed/NCBI
14	Edfeldt K, Swedenborg J, Hansson GK and Yan ZQ: Expression of toll-like receptors in human atherosclerotic lesions: A possible pathway for plaque activation. Circulation. 105:1158–1161. 2002.PubMed/NCBI
15	Razin A, Webb C, Szyf M, Yisraeli J, Rosenthal A, Naveh-Many T, Sciaky-Gallili N and Cedar H: Variations in DNA methylation during mouse cell differentiation in vivo and in vitro. Proc Natl Acad Sci USA. 81:2275–2279. 1984. View Article : Google Scholar : PubMed/NCBI
16	Deaton AM and Bird A: CpG islands and the regulation of transcription. Genes Dev. 25:1010–1022. 2011. View Article : Google Scholar : PubMed/NCBI
17	Zhang LN, Liu PP, Wang L, Yuan F, Xu L, Xin Y, Fei LJ, Zhong QL, Huang Y, Xu L, et al: Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension. PLoS One. 8:e634552013. View Article : Google Scholar : PubMed/NCBI
18	Fan R, Mao S, Zhong F, Gong M, Yin F, Hao L and Zhang L: Association of AGTR1 promoter methylation levels with essential hypertension risk: A Matched Case-Control Study. Cytogenet Genome Res. 147:95–102. 2015. View Article : Google Scholar : PubMed/NCBI
19	Fan R, Wang WJ, Zhong QL, Duan SW, Xu XT, Hao LM, Zhao J and Zhang LN: Aberrant methylation of the GCK gene body is associated with the risk of essential hypertension. Mol Med Rep. 12:2390–2394. 2015.PubMed/NCBI
20	European Society of Hypertension-European Society of Cardiology Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 21:1011–1053. 2003. View Article : Google Scholar : PubMed/NCBI
21	Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M and Morgenstern BZ: Human blood pressure determination by sphygmomanometry. Circulation. 88:2460–2470. 1993. View Article : Google Scholar : PubMed/NCBI
22	Bassil CF, Huang Z and Murphy SK: Bisulfite pyrosequencing. Methods Mol Biol. 1049:95–107. 2013. View Article : Google Scholar : PubMed/NCBI
23	Mikeska T, Felsberg J, Hewitt CA and Dobrovic A: Analysing DNA methylation using bisulphite pyrosequencing. Methods Mol Biol. 791:33–53. 2011. View Article : Google Scholar : PubMed/NCBI
24	Beaulieu LM, Lin E, Morin KM, Tanriverdi K and Freedman JE: Regulatory effects of TLR2 on megakaryocytic cell function. Blood. 117:5963–5974. 2011. View Article : Google Scholar : PubMed/NCBI
25	West XZ, Malinin NL, Merkulova AA, Tischenko M, Kerr BA, Borden EC, Podrez EA, Salomon RG and Byzova TV: Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature. 467:972–976. 2010. View Article : Google Scholar : PubMed/NCBI
26	West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, Walsh MC, Choi Y, Shadel GS and Ghosh S: TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature. 472:476–480. 2011. View Article : Google Scholar : PubMed/NCBI
27	Speer T, Rohrer L, Blyszczuk P, Shroff R, Kuschnerus K, Kränkel N, Kania G, Zewinger S, Akhmedov A, Shi Y, et al: Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2. Immunity. 38:754–768. 2013. View Article : Google Scholar : PubMed/NCBI
28	Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J and Wolffe AP: Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet. 19:187–191. 1998. View Article : Google Scholar : PubMed/NCBI
29	Morita S, Takahashi RU, Yamashita R, Toyoda A, Horii T, Kimura M, Fujiyama A, Nakai K, Tajima S, Matoba R, et al: Genome-wide analysis of DNA methylation and expression of microRNAs in breast cancer cells. Int J Mol Sci. 13:8259–8272. 2012. View Article : Google Scholar : PubMed/NCBI
30	Jones PA and Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet. 3:415–428. 2002.PubMed/NCBI
31	Liu Y, Liu P, Yang C, Cowley AW Jr and Liang M: Base-resolution maps of 5-methylcytosine and 5-hydroxymethylcytosine in Dahl S rats: Effect of salt and genomic sequence. Hypertension. 63:827–838. 2014. View Article : Google Scholar : PubMed/NCBI
32	Jones PA and Takai D: The role of DNA methylation in mammalian epigenetics. Science. 293:1068–1070. 2001. View Article : Google Scholar : PubMed/NCBI
33	Shuto T, Furuta T, Oba M, Xu H, Li JD, Cheung J, Gruenert DC, Uehara A, Suico MA, Okiyoneda T and Kai H: Promoter hypomethylation of Toll-like receptor-2 gene is associated with increased proinflammatory response toward bacterial peptidoglycan in cystic fibrosis bronchial epithelial cells. FASEB J. 20:782–784. 2006.PubMed/NCBI
34	Benakanakere M, Abdolhosseini M, Hosur K, Finoti LS and Kinane DF: TLR2 promoter hypermethylation creates innate immune dysbiosis. J Dent Res. 94:183–191. 2015. View Article : Google Scholar : PubMed/NCBI
35	Yang G, Zhu Y, Dong X, Duan Z, Niu X and Wei J: TLR2-ICAM1-Gadd45α axis mediates the epigenetic effect of selenium on DNA methylation and gene expression in Keshan disease. Biol Trace Elem Res. 159:69–80. 2014. View Article : Google Scholar : PubMed/NCBI
36	Sung KC, Suh JY, Kim BS, Kang JH, Kim H, Lee MH, Park JR and Kim SW: High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens. 16:429–433. 2003. View Article : Google Scholar : PubMed/NCBI
37	Bautista LE, López-Jaramillo P, Vera LM, Casas JP, Otero AP and Guaracao AI: Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens. 19:857–861. 2001. View Article : Google Scholar : PubMed/NCBI
38	Chae CU, Lee RT, Rifai N and Ridker PM: Blood pressure and inflammation in apparently healthy men. Hypertension. 38:399–403. 2001. View Article : Google Scholar : PubMed/NCBI
39	Ito H, Ohshima A, Tsuzuki M, Ohto N, Takao K, Hijii C, Yanagawa M, Ogasawara M and Nishioka K: Association of serum tumour necrosis factor-alpha with serum low-density lipoprotein-cholesterol and blood pressure in apparently healthy Japanese women. Clin Exp Pharmacol Physiol. 28:188–192. 2001. View Article : Google Scholar : PubMed/NCBI
40	Dou CY, Fan YC, Cao CJ, Yang Y and Wang K: Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma. Dig Dis Sci. 61:1130–1138. 2016. View Article : Google Scholar : PubMed/NCBI
41	Konecny M, Markus J, Waczulikova I, Dolesova L, Kozlova R, Repiska V, Novosadova H and Majer I: The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders. Neoplasma. 63:246–253. 2016.PubMed/NCBI
42	Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, Elston RC and Li MD: A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet. 80:1125–1137. 2007. View Article : Google Scholar : PubMed/NCBI